{
  "trial_id": "NCT04004702",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Meet the National Institute of Aging-Alzheimer's Association criteria for probable AD",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Twelve-item Neuropsychiatric Inventory with score 4 or greater",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "MMSE <26",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Stable doses current medications, including acetylcholinesterase inhibitors if applicable, for at least 4 weeks prior to trial entry",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Reliable caregiver willing and available to assist with medication administration, outcome measures",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous Epilepsy diagnosis",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Use of anti-epileptic medication for any indication within previous three months",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has a history of epilepsy and is currently on valium, which may trigger seizures. He also had a recent seizure episode.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT04004702",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}